Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» abelacimab
abelacimab
Anthos hails win over Xarelto with novel anticoagulant
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Flag link:
Anthos doubles down on its novel blood thinner
Anthos doubles down on its novel blood thinner
EP Vantage
Anthos
Novartis
Factor XI inhibitor
bloodthinners
abelacimab
Flag link:
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
Pharmaceutical Business Review
Anthos Therapeutics
Factor XI inhibitor
abelacimab
fast track
FDA
cancer
Flag link:
